SECTOR GAMMA AS

**SECTOR GAMMA AS** manages $439M across a concentrated portfolio of 36 positions, exhibiting a clear focus on the biotechnology and pharmaceutical sectors. The fund's top holdings are heavily weighted toward established biopharma leaders, notably BMY ($40.2M) and MRK ($38.3M). Significant allocations are also maintained in MDT ($25.9M), BDX ($25.7M), and GILD ($21.7M), suggesting a deep conviction in specialized drug development and market leaders. This structure points to a highly selective, sector-specific investment mandate within the life sciences space.

📌 Top Holdings